These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5941685)

  • 1. [Serum iron and copper levels and serum activity of phosphohexoisomerase and glutamic-pyruvic transaminase in patients with liver and biliary tract disease].
    Switlik I; Szymańska H; Myśliwicz-Rychlik H
    Pol Arch Med Wewn; 1966; 36(3):365-70. PubMed ID: 5941685
    [No Abstract]   [Full Text] [Related]  

  • 2. [The diagnostic value of determining serum iron and copper levels and activity of phosphohexoisomerase and pyruvic-glutamic transaminase in viral hepatitis].
    Myśliwicz-Rychlik H; Szymańska H; Switlik I
    Pol Arch Med Wewn; 1966; 36(2):231-7. PubMed ID: 5939632
    [No Abstract]   [Full Text] [Related]  

  • 3. [The valve of the determination of the ornithine-carbamyl transferase in the serum and its comparison with the determination of the glutamo-pyruvic transaminase in clinical hepatology].
    Cachin M; Girard ML; Charbonnier A; Rousselet F; Koch M; Khoury K
    Pathol Biol; 1965 May; 13(9):477-88. PubMed ID: 5320274
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of glutamic pyruvic transaminase in pyridoxine deficiency in liver disease.
    Ning M; Baker H; Leevy CM
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):27-30. PubMed ID: 5902945
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of glutamic acid dehydrogenase in serum of patients with liver diseases].
    Hankiewicz J; Antes B
    Pol Arch Med Wewn; 1965; 35(6):767-70. PubMed ID: 5837283
    [No Abstract]   [Full Text] [Related]  

  • 6. The studies on glycolytic enzymes in relation to cancer. II. Comparative study of phosphohexose-isomerase, aldolase, isocitric dehydrogenase, serum glutamic oxaloacetic and pyruvic transaminase, and alkaline phosphatase in liver.
    Damle SR; Talavdekar RV; Panse TB
    Indian J Cancer; 1971 Mar; 8(1):21-9. PubMed ID: 5559573
    [No Abstract]   [Full Text] [Related]  

  • 7. [The glutamic pyruvic transaminase-alkaline phosphatase quotient in hepatic pathology].
    Ledro Molina D
    Rev Esp Enferm Apar Dig; 1974 Mar; 43(2):183-92. PubMed ID: 4840487
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statistical evaluation of glutamic-oxaloacetic and glutamic-pyruvic serum transaminase in some diseases of the digestive system].
    Barisone D; Accardo S; Schenardi C
    Arch Maragliano Patol Clin; 1969; 25(4):297-315. PubMed ID: 5408925
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values.
    Gault MH; Stein J; Aronoff A
    Gastroenterology; 1966 Jan; 50(1):8-18. PubMed ID: 5900960
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic copper content, urinary copper excretion, and serum ceruloplasmin in liver disease.
    Ritland S; Steinnes E; Skrede S
    Scand J Gastroenterol; 1977; 12(1):81-8. PubMed ID: 834974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Sellek-Frade copper acetate test and glutamic-oxalacetic and glutamic-pyruvic transaminase activity in the sera of children with liver disease].
    SELLEK A; DEL FRADE A
    Arch Med Infant; 1959; 28():107-21. PubMed ID: 14444731
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aspartate aminotransferase (glutamic oxalacetic transaminase) and alanine aminotransferase (glutamic pyruvic transaminase)].
    Yoneda K
    Rinsho Byori; 2001 Nov; Suppl 116():72-80. PubMed ID: 11797383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic transaminase activity in alocholic liver disease.
    Matloff DS; Selinger MJ; Kaplan MM
    Gastroenterology; 1980 Jun; 78(6):1389-92. PubMed ID: 7372058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood iron and copper in hepatobiliary disease].
    BUTZENGEIGER KH; LANGE J
    Dtsch Arch Klin Med; 1952; 199(5-6):633-47. PubMed ID: 13033529
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes.
    Ito S; Takaoka T; Nakaya Y; Hiasa Y; Mori H; Tanaka K; Ichihara A
    Gastroenterology; 1982 Nov; 83(5):1102-8. PubMed ID: 6288507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cholesterol metabolism disorders in digestive pathology. II].
    Rautureau J; Coste T; Rautureau M
    Arch Fr Mal App Dig; 1972 Aug; 61(8):497-506. PubMed ID: 4567365
    [No Abstract]   [Full Text] [Related]  

  • 17. [The glutamic pyruvic transaminase/alkaline phosphate relation in hepatobiliary pathology].
    Ledro Molina D
    Rev Esp Enferm Apar Dig; 1977 May; 50(3):295-8. PubMed ID: 877372
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid metabolism in liver and biliary tract diseases].
    Takahashi Y; Fukazawa T
    Naika; 1968 Oct; 22(4):831-9. PubMed ID: 5707872
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of disease states on the pharmacokinetics of drugs. 2. Liver and biliary diseases].
    Pfeifer S
    Pharmazie; 1991 Sep; 46(9):623-32. PubMed ID: 1798726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of serum isocitrate dehydrogenase in patients with hepatobiliary diseases].
    Cremer Nicolini G
    An Fac Med Lima; 1965 Jun; 48(2):297-317. PubMed ID: 5850391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.